 |
PDBsum entry 1l8k
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.3.48
- protein-tyrosine-phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
O-phospho-L-tyrosyl-[protein] + H2O = L-tyrosyl-[protein] + phosphate
|
 |
 |
 |
 |
 |
O-phospho-L-tyrosyl-[protein]
|
+
|
H2O
|
=
|
L-tyrosyl-[protein]
|
+
|
phosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
277:19982-19990
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure determination of T cell protein-tyrosine phosphatase.
|
|
L.F.Iversen,
K.B.Moller,
A.K.Pedersen,
G.H.Peters,
A.S.Petersen,
H.S.Andersen,
S.Branner,
S.B.Mortensen,
N.P.Moller.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Protein-tyrosine phosphatase 1B (PTP1B) has recently received much attention as
a potential drug target in type 2 diabetes. This has in particular been spurred
by the finding that PTP1B knockout mice show increased insulin sensitivity and
resistance to diet-induced obesity. Surprisingly, the highly homologous T cell
protein-tyrosine phosphatase (TC-PTP) has received much less attention, and no
x-ray structure has been provided. We have previously co-crystallized PTP1B with
a number of low molecular weight inhibitors that inhibit TC-PTP with similar
efficiency. Unexpectedly, we were not able to co-crystallize TC-PTP with the
same set of inhibitors. This seems to be due to a multimerization process where
residues 130-132, the DDQ loop, from one molecule is inserted into the active
site of the neighboring molecule, resulting in a continuous string of
interacting TC-PTP molecules. Importantly, despite the high degree of functional
and structural similarity between TC-PTP and PTP1B, we have been able to
identify areas close to the active site that might be addressed to develop
selective inhibitors of each enzyme.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Chemical structures.
|
 |
Figure 6.
Fig. 6. Grasp rendering of the PTP1B and TC-PTP surfaces.
The two surface areas with structural differences useful for
potential selectivity design are indicated by white and yellow
circles, respectively. The surface electrostatic potentials are
colored in blue for positive charges and in red for negative
charges.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2002,
277,
19982-19990)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.M.Doody,
A.Bourdeau,
and
M.L.Tremblay
(2009).
T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease.
|
| |
Immunol Rev,
228,
325-341.
|
 |
|
|
|
|
 |
K.Bharatham,
N.Bharatham,
Y.J.Kwon,
and
K.W.Lee
(2008).
Molecular dynamics simulation study of PTP1B with allosteric inhibitor and its application in receptor based pharmacophore modeling.
|
| |
J Comput Aided Mol Des,
22,
925-933.
|
 |
|
|
|
|
 |
L.Tabernero,
A.R.Aricescu,
E.Y.Jones,
and
S.E.Szedlacsek
(2008).
Protein tyrosine phosphatases: structure-function relationships.
|
| |
FEBS J,
275,
867-882.
|
 |
|
|
|
|
 |
S.Mitra,
and
A.M.Barrios
(2008).
Identifying selective protein tyrosine phosphatase substrates and inhibitors from a fluorogenic, combinatorial peptide library.
|
| |
Chembiochem,
9,
1216-1219.
|
 |
|
|
|
|
 |
V.Sangwan,
G.N.Paliouras,
J.V.Abella,
N.Dubé,
A.Monast,
M.L.Tremblay,
and
M.Park
(2008).
Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase.
|
| |
J Biol Chem,
283,
34374-34383.
|
 |
|
|
|
|
 |
L.I.Pao,
K.Badour,
K.A.Siminovitch,
and
B.G.Neel
(2007).
Nonreceptor protein-tyrosine phosphatases in immune cell signaling.
|
| |
Annu Rev Immunol,
25,
473-523.
|
 |
|
|
|
|
 |
X.Y.Zhang,
and
A.C.Bishop
(2007).
Site-specific incorporation of allosteric-inhibition sites in a protein tyrosine phosphatase.
|
| |
J Am Chem Soc,
129,
3812-3813.
|
 |
|
|
|
|
 |
E.W.Yue,
B.Wayland,
B.Douty,
M.L.Crawley,
E.McLaughlin,
A.Takvorian,
Z.Wasserman,
M.J.Bower,
M.Wei,
Y.Li,
P.J.Ala,
L.Gonneville,
R.Wynn,
T.C.Burn,
P.C.Liu,
and
A.P.Combs
(2006).
Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: synthesis and structure-activity relationships of a peptide scaffold.
|
| |
Bioorg Med Chem,
14,
5833-5849.
|
 |
|
|
|
|
 |
P.D.Simoncic,
C.J.McGlade,
and
M.L.Tremblay
(2006).
PTP1B and TC-PTP: novel roles in immune-cell signaling.
|
| |
Can J Physiol Pharmacol,
84,
667-675.
|
 |
|
|
|
|
 |
A.K.Pedersen,
G.H.Peters G,
K.B.Møller,
L.F.Iversen,
and
J.S.Kastrup
(2004).
Water-molecule network and active-site flexibility of apo protein tyrosine phosphatase 1B.
|
| |
Acta Crystallogr D Biol Crystallogr,
60,
1527-1534.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.D.Taylor,
and
B.Hill
(2004).
Recent advances in protein tyrosine phosphatase 1B inhibitors.
|
| |
Expert Opin Investig Drugs,
13,
199-214.
|
 |
|
|
|
|
 |
T.O.Johnson,
J.Ermolieff,
and
M.R.Jirousek
(2002).
Protein tyrosine phosphatase 1B inhibitors for diabetes.
|
| |
Nat Rev Drug Discov,
1,
696-709.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |